What Geftinat Capsule is?
Gefitinib is an Epidermal Growth factor Receptor (EGFR) inhibitor indicated as the monotherapy for the treatment of patients with locally advanced or metastatic NSCLC (Non-Small Cell Lung Cancer) after the failure of both docetaxel and platinum-based chemotherapies.
Because it is a selective chemotherapeutic agent so the tolerability profile of this medication (Geftinat) quite better and impressive than the previous cytotoxic agents.
What Gefitinib is?
Gefitinib (trade name Iressa)is a drug used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells.